JP2006524706A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006524706A5 JP2006524706A5 JP2006513319A JP2006513319A JP2006524706A5 JP 2006524706 A5 JP2006524706 A5 JP 2006524706A5 JP 2006513319 A JP2006513319 A JP 2006513319A JP 2006513319 A JP2006513319 A JP 2006513319A JP 2006524706 A5 JP2006524706 A5 JP 2006524706A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- alkyl
- hydrogen
- heteroaryl
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229910052739 hydrogen Inorganic materials 0.000 claims 42
- 239000001257 hydrogen Substances 0.000 claims 42
- 150000002431 hydrogen Chemical group 0.000 claims 34
- 125000001072 heteroaryl group Chemical group 0.000 claims 26
- 150000001875 compounds Chemical class 0.000 claims 17
- 150000002148 esters Chemical class 0.000 claims 17
- 239000000651 prodrug Substances 0.000 claims 17
- 229940002612 prodrug Drugs 0.000 claims 17
- 150000003839 salts Chemical class 0.000 claims 17
- -1 wherein Chemical compound 0.000 claims 16
- 125000003118 aryl group Chemical group 0.000 claims 12
- 229910052736 halogen Inorganic materials 0.000 claims 11
- 150000002367 halogens Chemical class 0.000 claims 11
- 125000003107 substituted aryl group Chemical group 0.000 claims 11
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 10
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 claims 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 7
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 5
- 125000001424 substituent group Chemical group 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 4
- 125000006710 (C2-C12) alkenyl group Chemical group 0.000 claims 3
- 125000006711 (C2-C12) alkynyl group Chemical group 0.000 claims 3
- 208000035143 Bacterial infection Diseases 0.000 claims 3
- 208000022362 bacterial infectious disease Diseases 0.000 claims 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 3
- 125000004642 (C1-C12) alkoxy group Chemical group 0.000 claims 2
- 125000001843 C4-C10 alkenyl group Chemical group 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 125000002883 imidazolyl group Chemical group 0.000 claims 2
- 125000006584 (C3-C10) heterocycloalkyl group Chemical group 0.000 claims 1
- YKYIFUROKBDHCY-ONEGZZNKSA-N (e)-4-ethoxy-1,1,1-trifluorobut-3-en-2-one Chemical group CCO\C=C\C(=O)C(F)(F)F YKYIFUROKBDHCY-ONEGZZNKSA-N 0.000 claims 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- XBPASXLWMTZZFC-UHFFFAOYSA-N 4-[4-(6-chloropyridin-3-yl)-2-methyl-1h-imidazol-5-yl]butan-1-amine Chemical compound N1C(C)=NC(C=2C=NC(Cl)=CC=2)=C1CCCCN XBPASXLWMTZZFC-UHFFFAOYSA-N 0.000 claims 1
- OIKYGVHOAKNOIT-UHFFFAOYSA-N 4-[4-(6-chloropyridin-3-yl)-5-methyl-1h-imidazol-2-yl]butan-1-amine Chemical compound N1C(CCCCN)=NC(C=2C=NC(Cl)=CC=2)=C1C OIKYGVHOAKNOIT-UHFFFAOYSA-N 0.000 claims 1
- SKSZYTFXIDNVRR-UHFFFAOYSA-N 4-[4-(6-chloropyridin-3-yl)imidazol-1-yl]butan-1-amine Chemical compound NCCCCN1C=NC(C=2C=NC(Cl)=CC=2)=C1 SKSZYTFXIDNVRR-UHFFFAOYSA-N 0.000 claims 1
- KQPJSTREOMVENQ-UHFFFAOYSA-N 4-[4-(6-ethoxypyridin-3-yl)imidazol-1-yl]butan-1-amine Chemical compound C1=NC(OCC)=CC=C1C1=CN(CCCCN)C=N1 KQPJSTREOMVENQ-UHFFFAOYSA-N 0.000 claims 1
- VYBHXZVSJYBFMA-UHFFFAOYSA-N 4-[4-(6-fluoropyridin-3-yl)imidazol-1-yl]butan-1-amine Chemical compound NCCCCN1C=NC(C=2C=NC(F)=CC=2)=C1 VYBHXZVSJYBFMA-UHFFFAOYSA-N 0.000 claims 1
- IYWJLGFXMICCGN-UHFFFAOYSA-N 4-[4-(6-methoxypyridin-3-yl)imidazol-1-yl]butan-1-amine Chemical compound C1=NC(OC)=CC=C1C1=CN(CCCCN)C=N1 IYWJLGFXMICCGN-UHFFFAOYSA-N 0.000 claims 1
- FMZZOIPURNVGLD-UHFFFAOYSA-N 4-[4-(6-methylpyridin-3-yl)imidazol-1-yl]butan-1-amine Chemical compound C1=NC(C)=CC=C1C1=CN(CCCCN)C=N1 FMZZOIPURNVGLD-UHFFFAOYSA-N 0.000 claims 1
- LZPSNHQTMJQMHZ-UHFFFAOYSA-N 4-[5-(4-chloropyridin-3-yl)-1h-imidazol-2-yl]butan-1-amine Chemical compound N1C(CCCCN)=NC=C1C1=CN=CC=C1Cl LZPSNHQTMJQMHZ-UHFFFAOYSA-N 0.000 claims 1
- DFAGLOLGEMMVPT-UHFFFAOYSA-N 4-[5-(4-methoxypyridin-3-yl)-1h-imidazol-2-yl]butan-1-amine Chemical compound COC1=CC=NC=C1C1=CN=C(CCCCN)N1 DFAGLOLGEMMVPT-UHFFFAOYSA-N 0.000 claims 1
- 125000004042 4-aminobutyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])N([H])[H] 0.000 claims 1
- FWMIGRYEXUCAOR-UHFFFAOYSA-N 5-[1-(4-aminobutyl)imidazol-4-yl]-n-methylpyridin-2-amine Chemical compound C1=NC(NC)=CC=C1C1=CN(CCCCN)C=N1 FWMIGRYEXUCAOR-UHFFFAOYSA-N 0.000 claims 1
- UGBFATORHKYKHA-UHFFFAOYSA-N 5-[1-(4-aminobutyl)imidazol-4-yl]pyridin-2-amine Chemical compound NCCCCN1C=NC(C=2C=NC(N)=CC=2)=C1 UGBFATORHKYKHA-UHFFFAOYSA-N 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 125000002140 imidazol-4-yl group Chemical group [H]N1C([H])=NC([*])=C1[H] 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- ROSDSFDQCJNGOL-UHFFFAOYSA-N protonated dimethyl amine Natural products CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 claims 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims 1
- 0 CCC([C@](C)([C@@]([C@@](C)C([C@](C)C[C@](C)(*C)[C@](*C([C@@]1O)O[C@](C)C[C@@]1N(C)C)[C@@](C)C([C@]1C)=O)=O)N2CCCCC(C3)C=NC3C(CC3)=CN=C3Cl)OC2=O)OC1=O Chemical compound CCC([C@](C)([C@@]([C@@](C)C([C@](C)C[C@](C)(*C)[C@](*C([C@@]1O)O[C@](C)C[C@@]1N(C)C)[C@@](C)C([C@]1C)=O)=O)N2CCCCC(C3)C=NC3C(CC3)=CN=C3Cl)OC2=O)OC1=O 0.000 description 2
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46533703P | 2003-04-25 | 2003-04-25 | |
| PCT/US2004/012778 WO2004096823A2 (en) | 2003-04-25 | 2004-04-23 | Novel ketolide derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006524706A JP2006524706A (ja) | 2006-11-02 |
| JP2006524706A5 true JP2006524706A5 (OSRAM) | 2007-05-10 |
Family
ID=33418228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006513319A Pending JP2006524706A (ja) | 2003-04-25 | 2004-04-23 | 新規なケトライド誘導体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US7163924B2 (OSRAM) |
| EP (1) | EP1618120A2 (OSRAM) |
| JP (1) | JP2006524706A (OSRAM) |
| CA (1) | CA2523541A1 (OSRAM) |
| WO (1) | WO2004096823A2 (OSRAM) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1638549A4 (en) | 2003-03-10 | 2011-06-15 | Optimer Pharmaceuticals Inc | NEW ANTIBACTERIAL AGENTS |
| JP2006524702A (ja) * | 2003-04-25 | 2006-11-02 | カイロン コーポレイション | ピリジル置換ケトライド抗体 |
| JP2009506066A (ja) | 2005-08-24 | 2009-02-12 | リブ−エックス ファーマシューティカルズ，インコーポレイテッド | トリアゾール化合物ならびにこれを作製する方法および使用する方法 |
| EP1960413A2 (en) * | 2005-11-23 | 2008-08-27 | Ranbaxy Laboratories Limited | Macrolides derivatives as antibacterial agents |
| CN100494191C (zh) * | 2007-02-02 | 2009-06-03 | 广东东阳光药业有限公司 | 一种制备3-(咪唑-4-基)吡啶的方法 |
| CA2703475A1 (en) * | 2007-10-25 | 2009-04-30 | Cempra Pharmaceuticals, Inc. | Process for the preparation of macrolide antibacterial agents |
| US8796232B2 (en) * | 2008-10-24 | 2014-08-05 | Cempra Pharmaceuticals, Inc. | Methods for treating resistant diseases using triazole containing macrolides |
| RU2011153353A (ru) | 2009-05-27 | 2013-07-10 | Вокхардт Рисерч Сентер | Кетолидные соединения, обладающие противомикробной активностью |
| US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
| JP5914335B2 (ja) | 2009-09-10 | 2016-05-11 | センプラ ファーマシューティカルズ，インコーポレイテッド | マラリア、結核、及びｍａｃ病の治療方法 |
| CN103080122A (zh) | 2010-03-22 | 2013-05-01 | 森普拉制药公司 | 大环内脂的结晶形式及其用途 |
| WO2011146829A1 (en) | 2010-05-20 | 2011-11-24 | Cempra Pharmaceuticals, Inc. | Processes for preparing macrolides and ketolides and intermediates therefor |
| US8796474B1 (en) | 2010-08-23 | 2014-08-05 | Rutgers, The State University Of New Jersey | Macrolide compounds and methods and intermediates useful for their preparation |
| JP6042334B2 (ja) | 2010-09-10 | 2016-12-14 | センプラ ファーマシューティカルズ，インコーポレイテッド | 疾患治療のための水素結合形成フルオロケトライド |
| CN103619863B (zh) * | 2011-03-22 | 2016-03-16 | 沃克哈特有限公司 | 酮内酯化合物的制备方法 |
| CN104470527B (zh) | 2012-03-27 | 2019-05-28 | 森普拉制药公司 | 用于施用大环内酯抗生素的肠胃外制剂 |
| RU2015138796A (ru) | 2013-03-14 | 2017-04-19 | Семпра Фармасьютикалс, Инк. | Способы и составы для лечения респираторных заболеваний |
| WO2014145210A1 (en) | 2013-03-15 | 2014-09-18 | Cempra Pharmaceuticals, Inc. | Convergent processes for preparing macrolide antibacterial agents |
| CN103664788B (zh) * | 2013-12-04 | 2015-11-25 | 湖北生物医药产业技术研究院有限公司 | 制备美托咪啶的方法 |
| CN104650166B (zh) * | 2014-11-17 | 2017-12-05 | 广东东阳光药业有限公司 | 一种大环内酯的制备方法 |
| BR112019004243A2 (pt) * | 2016-08-29 | 2019-06-04 | Univ Texas | composto, composição farmacêutica, método para inibição de quinase do zíper de leucina dupla, método para tratamento de uma doença mediada por quinase do zíper de leucina dupla e método para obter um efeito em um paciente |
| CN110234323A (zh) * | 2016-10-04 | 2019-09-13 | Ti生物制药有限公司 | 具有抗菌活性的酮内酯 |
| US11560366B2 (en) | 2019-10-21 | 2023-01-24 | Board Of Regents, The University Of Texas System | Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4857641A (en) | 1987-08-14 | 1989-08-15 | Pfizer Inc. | C.12 modified erythromycin A derivatives |
| US6063561A (en) * | 1991-01-17 | 2000-05-16 | Abbott Laboratories | Polyketide derivatives and recombinant methods for making same |
| FR2718450B1 (fr) * | 1994-04-08 | 1997-01-10 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
| FR2719587B1 (fr) * | 1994-05-03 | 1996-07-12 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
| WO1997042204A1 (en) * | 1996-05-07 | 1997-11-13 | Abbott Laboratories | 6-o-substituted erythromycins and method for making them |
| US5750510A (en) * | 1997-04-04 | 1998-05-12 | Abbott Laboratories | 3-descladinose-2,3-anhydroerythromycin derivatives |
| UA51730C2 (uk) * | 1996-09-04 | 2002-12-16 | Ебботт Лабораторіз | 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців |
| SK285534B6 (sk) * | 1996-09-04 | 2007-03-01 | Abbott Laboratories | 6-O-substituované ketolidy s antibakteriálnou aktivitou, farmaceutická kompozícia s ich obsahom, ich použitie a spôsob ich prípravy |
| CA2272620A1 (en) | 1996-11-27 | 1998-06-04 | Taisho Pharmaceutical Co., Ltd. | Erythromycin a derivatives |
| WO1998042720A1 (fr) | 1997-03-24 | 1998-10-01 | Taisho Pharmaceutical Co., Ltd. | Derives d'erythromycine a |
| US6124269A (en) * | 1997-10-29 | 2000-09-26 | Abbott Laboratories | 2-Halo-6-O-substituted ketolide derivatives |
| AP1060A (en) | 1998-01-02 | 2002-04-23 | Pfizer Prod Inc | Novel erythromycin derivatives. |
| US6355620B1 (en) | 1999-05-14 | 2002-03-12 | Abbott Laboratories | C-2 modified erythromycin derivatives |
| JP4509553B2 (ja) * | 2001-07-03 | 2010-07-21 | ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド | 抗菌活性を有するｃ１２修飾エリスロマイシンマクロライドおよびケトライド |
| JP2006524702A (ja) * | 2003-04-25 | 2006-11-02 | カイロン コーポレイション | ピリジル置換ケトライド抗体 |
-
2004
- 2004-04-23 EP EP04760380A patent/EP1618120A2/en not_active Withdrawn
- 2004-04-23 US US10/831,522 patent/US7163924B2/en not_active Expired - Fee Related
- 2004-04-23 CA CA002523541A patent/CA2523541A1/en not_active Abandoned
- 2004-04-23 WO PCT/US2004/012778 patent/WO2004096823A2/en not_active Ceased
- 2004-04-23 JP JP2006513319A patent/JP2006524706A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005527587A5 (OSRAM) | ||
| JP2003521537A5 (OSRAM) | ||
| JP2004522461A5 (OSRAM) | ||
| JP2006514626A5 (OSRAM) | ||
| JP2006507355A5 (OSRAM) | ||
| JP2007524696A5 (OSRAM) | ||
| JP2006505543A5 (OSRAM) | ||
| JP2007522098A5 (OSRAM) | ||
| SK285151B6 (sk) | Neutrálna forma S-enantioméru omeprazolu, spôsob jeho prípravy, farmaceutická kompozícia s jeho obsahom a jeho použitie | |
| JP2004507543A5 (OSRAM) | ||
| JP2018525426A5 (OSRAM) | ||
| WO1996030362A1 (en) | Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases | |
| JP2005506348A5 (OSRAM) | ||
| CA2631880A1 (en) | Chromane substituted benzimidazoles and their use as acid pump inhibitors | |
| JP2009519243A5 (OSRAM) | ||
| JP2005526857A5 (OSRAM) | ||
| JP2016514719A5 (OSRAM) | ||
| KR870001196A (ko) | 피리딘 화합물과 그의 제법 및 그를 함유하는 약학조성물 | |
| JP2002540137A5 (OSRAM) | ||
| JP2004502761A5 (OSRAM) | ||
| JP2002506444A (ja) | ファルネシルタンパク質トランスフェラーゼの新規ｎ置換尿素インヒビター | |
| JP2003525850A5 (OSRAM) | ||
| JP2007516205A5 (OSRAM) | ||
| JP2006524702A5 (OSRAM) | ||
| JP2004507521A5 (OSRAM) |